Novoray Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 4/6

Novoray verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 21.5%, während die Gewinne der Branche Chemicals jährlich um gewachsen und zwar um 7.9%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 19.9%. Die Eigenkapitalrendite von Novoray beträgt 14.1% und die Nettomargen betragen 25.6%.

Wichtige Informationen

20.3%

Wachstumsrate der Gewinne

16.9%

EPS-Wachstumsrate

Chemicals Wachstum der Industrie	12.1%
Wachstumsrate der Einnahmen	19.5%
Eigenkapitalrendite	15.9%
Netto-Marge	26.0%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01

Recent updates

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27

Aufschlüsselung der Einnahmen und Ausgaben

Wie Novoray Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

SHSE:688300 Einnahmen, Ausgaben und Erträge (CNY Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten	F&E-Ausgaben
30 Jun 24	841	218	65	55
31 Mar 24	769	197	61	51
31 Dec 23	712	174	59	47
30 Sep 23	685	182	60	45
30 Jun 23	625	169	57	39
31 Mar 23	630	174	55	38
31 Dec 22	662	188	51	38
30 Sep 22	657	175	47	38
30 Jun 22	686	186	45	40
31 Mar 22	663	179	46	38
31 Dec 21	625	173	46	35
30 Sep 21	581	169	49	30
30 Jun 21	522	147	49	26
31 Mar 21	473	130	44	24
31 Dec 20	404	111	44	20
30 Sep 20	367	92	46	19
30 Jun 20	341	82	45	16
31 Mar 20	321	78	50	13
31 Dec 19	315	75	48	13
30 Sep 19	298	69	43	12
30 Jun 19	292	67	41	12
31 Mar 19	277	60	38	11
31 Dec 18	278	58	38	11
30 Sep 18	264	54	37	10
30 Jun 18	249	50	37	10
31 Mar 18	230	46	34	9
31 Dec 17	211	42	32	8
30 Sep 17	193	41	31	6
30 Jun 17	176	39	31	3
31 Mar 17	165	36	32	2
31 Dec 16	154	33	33	0
30 Sep 16	143	27	32	0
30 Jun 16	132	20	31	0
31 Mar 16	127	19	30	0
31 Dec 15	122	18	30	0
30 Sep 15	121	19	29	0
30 Jun 15	132	20	29	0
31 Mar 15	131	19	30	0
31 Dec 14	125	19	30	0
31 Dec 13	120	14	30	0

Qualität der Erträge: 688300 hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: 688300Die aktuellen Gewinnspannen (25.6%) sind niedriger als im letzten Jahr (27.7%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 688300In den letzten 5 Jahren sind die Einnahmen von 21.5% pro Jahr erheblich gestiegen.

Beschleunigtes Wachstum: 688300Das Gewinnwachstum des Unternehmens im letzten Jahr (29.2%) übertrifft seinen 5-Jahres-Durchschnitt (20.3% pro Jahr).

Erträge im Vergleich zur Industrie: 688300 Das Gewinnwachstum im vergangenen Jahr (13%) übertraf das der Branche Chemicals -16.4% .

Eigenkapitalrendite

Hohe Eigenkapitalrendite: 688300Die Eigenkapitalrendite des Unternehmens (14.1%) wird als niedrig angesehen.

Novoray Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)

Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024

First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Recent updates

Investor sentiment improves as stock rises 16%

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Price target increased by 18% to CN¥65.00

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Dividend of CN¥0.50 announced

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Novoray Corporation, Annual General Meeting, Apr 19, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)

Now 21% undervalued

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)

Investor sentiment improves as stock rises 32%

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: CN¥1.51 (vs CN¥1.39 in FY 2021)

Price target decreased to CN¥54.21

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.58 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.49 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target increased to CN¥118

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.58 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.29 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target increased to CN¥69.68

First quarter 2021 earnings released: EPS CN¥0.43 (vs CN¥0.21 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥40.31

New 90-day low: CN¥40.48

New 90-day low: CN¥47.02

Market pulls back on stock over the past week

New 90-day low: CN¥50.10

Third quarter earnings released

Analysts lower revenue estimates to CN¥394.0m

Novoray Corporation to Report Q3, 2020 Results on Oct 22, 2020

New 90-day low: CN¥51.88

New 90-day low - CN¥53.99

First half earnings released

Novoray Corporation to Report First Half, 2020 Results on Aug 26, 2020

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital